Sign in

You're signed outSign in or to get full access.

BI

BOWFLEX INC. (BFX)·Q3 2017 Earnings Summary

Executive Summary

  • Q3 2017 revenue grew 9% year over year to $88.1M, driven by Retail segment strength (+15.8% YoY) and stable Direct sales; diluted EPS increased to $0.27 (vs. $0.24), aided by lower selling and marketing expense from a $2.1M retroactive financing fee adjustment and a $1.0M indemnification settlement .
  • Mix shift and discounting pressure in Direct (TreadClimber declines) continued to weigh on Direct margins (Q3 Direct GM 63.5%, down 220 bps YoY), partly offset by Retail margin expansion (Retail GM +60 bps YoY) .
  • Operating income rose 63% YoY to $13.4M on leverage from lower operating expenses and Retail growth, despite higher cost of sales; tax rate normalized (36.8%) versus unusually low prior-year quarter due to non-recurring tax benefits in 2016 .
  • Cash/investments ended the quarter at $77.8M with $52.0M term loan outstanding; $20.0M revolver availability remained, and $18.2M was left under buyback authorization; 86,856 shares were repurchased in August ($1.42M) .

What Went Well and What Went Wrong

  • What Went Well

    • Retail momentum: Retail sales +15.8% YoY to $53.5M with broad growth across categories and channels; Retail GM expanded 60 bps YoY on better absorption and one-time settlement benefit .
    • Expense leverage: Selling and marketing down 15.7% YoY to $18.0M (20.5% of sales) on a retroactive financing fee rebate ($2.1M) and a $1.0M indemnification settlement, supporting EPS growth despite cost of sales increases .
    • Credit approvals improved: Combined consumer credit approvals increased to 53.7% vs. 47.9% a year ago, reflecting targeted media and stronger Tier 1 credit performance .
  • What Went Wrong

    • Direct margin pressure: Direct GM fell 220 bps YoY on unfavorable product mix and discounting for older products, with Direct gross profit down 2.5% YoY despite flat sales .
    • Tax rate normalization: Effective tax rate rose to 36.8% (vs. 1.9% last year), removing the prior-year tax tailwind and muting net income growth relative to operating gains .
    • Royalty revenue decline: Royalty revenue decreased to $0.64M from $0.89M, partially offsetting core growth .

Financial Results

Quarterly results (oldest → newest):

MetricQ1 2017Q2 2017Q3 2017
Revenue ($M)$113.3 $77.0 $88.1
Gross Profit ($M)$61.7 $38.4 $41.3
Operating Income ($M)$12.7 $3.8 $13.4
Net Income ($M)$7.1 $2.5 $8.2
Diluted EPS$0.23 $0.08 $0.27

Q3 year-over-year comparison:

MetricQ3 2016Q3 2017YoY
Revenue ($M)$80.8 $88.1 +9.0%
Diluted EPS$0.24 $0.27 +12.5%

Segment breakdown (Net Sales):

Segment ($M)Q3 2016Q3 2017
Direct$33.7 $34.0
Retail$46.2 $53.5
Royalty$0.89 $0.64
Total$80.8 $88.1

Segment gross margins across quarters:

Segment GM %Q1 2017Q2 2017Q3 2017
Direct GM %65.5% 63.3% 63.5%
Retail GM %32.0% 34.5% 35.7%

Product category mix (Q3):

Category ($M)Q3 2016Q3 2017
Direct – Cardio$30.5 $30.1
Direct – Strength$3.16 $3.90
Retail – Cardio$33.3 $39.4
Retail – Strength$12.9 $14.1

KPIs and operating drivers:

KPIQ1 2017Q2 2017Q3 2017
Consumer credit approvals52.6% 52.2% 53.7%
Direct media advertising ($M)$20.00 $12.59 $11.11

Balance sheet and capital allocation (end of Q3):

  • Cash & equivalents: $30.5M; Investments (AFS securities): $47.3M; Total cash/investments: $77.8M .
  • Term loan balance: $52.0M; Revolver availability: $20.0M; in covenant compliance .
  • Share repurchases during Q3: 86,856 shares for $1.42M; remaining authorization $18.19M .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
RevenueFY/Quarter (not specified)No formal guidance disclosed in reviewed filings (Q3 2017 10-Q) .
EPSFY/Quarter (not specified)No formal guidance disclosed in reviewed filings (Q3 2017 10-Q) .

Note: We found no explicit quantitative guidance ranges in the Q3 2017 SEC filing set reviewed .

Earnings Call Themes & Trends

Note: A Q3 2017 call occurred (external references exist), but full transcript was not available in our corpus; themes below reflect management’s MD&A commentary.

TopicPrevious Mentions (Q1 & Q2 2017)Current Period (Q3 2017)Trend
Direct channel pressure (TreadClimber)Direct cardio down; discounting weighed on margins Direct GM down YoY on mix/discounting; new products (HVT) offset some declines Stabilizing revenue, continued margin pressure
Retail channel growthRetail +4–13% with margin improvement Retail +15.8% YoY; GM +60 bps; broad category/channel growth Accelerating
Media efficiency/credit approvalsHigher media spend amid lower response; approvals ~52–53% Media $11.1M; approvals 53.7% (improved YoY) Improving credit approvals; tighter media spend
One-time itemsRoyalty dispute reserve reversal in Q2 reduced S&M Retro financing fee rebate ($2.1M) and $1.0M indemnification reduced S&M Non-recurring helps OpEx
Tax rateLower in Q1/Q2 from stock-based tax benefits Normalized to 36.8% vs. 1.9% LY (non-recurring prior-year items) Normalizing higher

Management Commentary

  • Strategy and positioning: “We are committed to providing innovative, quality solutions to help people achieve a fit and healthy lifestyle.” .
  • Channel dynamics: Retail growth reflected “traditional and e-commerce customers across multiple product categories,” while Direct faced “unfavorable product mix and higher discounting for older products.” .
  • Operating discipline: Selling and marketing declined on “retroactive contract adjustment of $2.1 million and receipt of a one-time settlement payment of $1.0 million for an indemnification claim.” .

Q&A Highlights

  • Full Q3 2017 earnings call transcript was not available in our corpus; therefore, specific Q&A themes and clarifications cannot be cited from primary sources.

Estimates Context

  • Wall Street consensus from S&P Global was not retrievable via our estimates tool for this ticker; as a result, we cannot quantify beats/misses versus S&P Global consensus for Q3 2017. Where estimates are unavailable, we default to company-reported results in SEC filings .

Key Takeaways for Investors

  • Retail-led growth with expanding Retail margins offset Direct margin pressure; mix and discounting in Direct remain the core headwind to watch .
  • Expense leverage (notably S&M) and one-time items boosted operating income and EPS; sustainability into subsequent quarters depends on media efficiency and the absence of non-recurring credits .
  • Credit approvals continue to improve (53.7%), supporting Direct demand conversion; continued focus on qualified media should aid unit economics .
  • Inventory built ahead of seasonally strong Q4; working capital management and sell-through at retail are near-term execution priorities .
  • Capital allocation remains supportive with buyback capacity ($18.2M remaining) and adequate liquidity ($77.8M cash/investments; full revolver availability) .
  • Watch list: trajectory of TreadClimber declines, adoption of newer products (e.g., HVT), Retail order patterns into holiday, and any freight/input cost pressures flowing through cost of sales .

Sources: SEC filings for the quarter ended September 30, 2017 and prior quarters .